Your browser doesn't support javascript.
loading
Accelerating diagnosis of Parkinson's disease through risk prediction.
Yuan, William; Beaulieu-Jones, Brett; Krolewski, Richard; Palmer, Nathan; Veyrat-Follet, Christine; Frau, Francesca; Cohen, Caroline; Bozzi, Sylvie; Cogswell, Meaghan; Kumar, Dinesh; Coulouvrat, Catherine; Leroy, Bruno; Fischer, Tanya Z; Sardi, S Pablo; Chandross, Karen J; Rubin, Lee L; Wills, Anne-Marie; Kohane, Isaac; Lipnick, Scott L.
Afiliação
  • Yuan W; Department of Biomedical Informatics, Harvard Medical School, 10 Shattuck Street, Suite 514, Boston, MA, 02115, USA.
  • Beaulieu-Jones B; Department of Biomedical Informatics, Harvard Medical School, 10 Shattuck Street, Suite 514, Boston, MA, 02115, USA.
  • Krolewski R; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, 02138, USA.
  • Palmer N; Department of Neurology, Brigham and Women's Hospital, Boston, MA, 02115, USA.
  • Veyrat-Follet C; Department of Biomedical Informatics, Harvard Medical School, 10 Shattuck Street, Suite 514, Boston, MA, 02115, USA.
  • Frau F; Sanofi, 1 Av. Pierre Brossolette, 91380, Chilly-Mazarin, France.
  • Cohen C; Sanofi-Aventis Deutschland GmbH, Industriepark Höchst, 65926, Frankfurt am Main, Germany.
  • Bozzi S; Sanofi, 1 Av. Pierre Brossolette, 91380, Chilly-Mazarin, France.
  • Cogswell M; Sanofi, 1 Av. Pierre Brossolette, 91380, Chilly-Mazarin, France.
  • Kumar D; Sanofi, 50 Binney St, Cambridge, MA, 02142, USA.
  • Coulouvrat C; Sanofi, 50 Binney St, Cambridge, MA, 02142, USA.
  • Leroy B; Sanofi, 1 Av. Pierre Brossolette, 91380, Chilly-Mazarin, France.
  • Fischer TZ; Sanofi, 1 Av. Pierre Brossolette, 91380, Chilly-Mazarin, France.
  • Sardi SP; Sanofi, 50 Binney St, Cambridge, MA, 02142, USA.
  • Chandross KJ; Sanofi, 50 Binney St, Cambridge, MA, 02142, USA.
  • Rubin LL; Sanofi R&D, 55 Corporate Drive, Bridgewater, NJ, 08807, USA.
  • Wills AM; Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA, 02138, USA.
  • Kohane I; Neurological Clinical Research Institute (NCRI), Massachusetts General Hospital (MGH), Boston, MA, 02114, USA.
  • Lipnick SL; Department of Biomedical Informatics, Harvard Medical School, 10 Shattuck Street, Suite 514, Boston, MA, 02115, USA.
BMC Neurol ; 21(1): 201, 2021 May 18.
Article em En | MEDLINE | ID: mdl-34006233
ABSTRACT

BACKGROUND:

Characterization of prediagnostic Parkinson's Disease (PD) and early prediction of subsequent development are critical for preventive interventions, risk stratification and understanding of disease pathology. This study aims to characterize the role of the prediagnostic period in PD and, using selected features from this period as novel interception points, construct a prediction model to accelerate the diagnosis in a real-world setting.

METHODS:

We constructed two sets of machine learning models a retrospective approach highlighting exposures up to 5 years prior to PD diagnosis, and an alternative model that prospectively predicted future PD diagnosis from all individuals at their first diagnosis of a gait or tremor disorder, these being features that appeared to represent the initiation of a differential diagnostic window.

RESULTS:

We found many novel features captured by the retrospective models; however, the high accuracy was primarily driven from surrogate diagnoses for PD, such as gait and tremor disorders, suggesting the presence of a distinctive differential diagnostic period when the clinician already suspected PD. The model utilizing a gait/tremor diagnosis as the interception point, achieved a validation AUC of 0.874 with potential time compression to a future PD diagnosis of more than 300 days. Comparisons of predictive diagnoses between the prospective and prediagnostic cohorts suggest the presence of distinctive trajectories of PD progression based on comorbidity profiles.

CONCLUSIONS:

Overall, our machine learning approach allows for both guiding clinical decisions such as the initiation of neuroprotective interventions and importantly, the possibility of earlier diagnosis for clinical trials for disease modifying therapies.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: BMC Neurol Assunto da revista: NEUROLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doença de Parkinson Tipo de estudo: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: BMC Neurol Assunto da revista: NEUROLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos